News Project seeks to shape digital health reimbursement in APAC APACMed and Eversana join forces to draw up coverage frameworks applicable to APAC countries.
News First major insurer covers Eisai’s Alzheimer’s drug Leqembi Department of Veterans Affairs will cover the drug for veterans with early-stage Alzheimer's.
News Bill seeks Medicare category for digital therapeutics Bipartisan bill would create a payment system for FDA-approved, prescription DTx products.
News Ex-NHS chief negotiator joins Newmarket Strategy Pharma veteran Blake Dark joins the healthcare and life sciences consultancy as senior partner.
News CMS accused of discrimination over Alzheimer’s drug verdict Decision not to revisit coverage decision for amyloid drugs is slammed by patient groups.
News BioMarin gets first access deal in EU for gene therapy Rocta... BioMarin's has signed the first contract with an insurer in Germany for Roctavian, its recently approved gene therapy for haemophilia A, as it tests out its outcomes-based agreement (OBA) r
News US pharma tariffs of up to 100% finalised by Trump Trump signs his pharma tariffs executive order, which won't affect most large pharma groups but could deal a hefty blow to smaller companies.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
